Fundraising Fox
/People
Sign in

Melissa McCracken

Investor

Partner at Nextech Invest · Board director at Ambagon Therapeutics

USA

Writes $100K – $5M checks · typically $1.5M

Kauffman Fellow · Class 25

Find your path to Melissa

1,285 people in our graph can introduce you to Melissa.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Aleks Radovic-Moreno to introduce you to Melissa

You →Aleks · together at Be Biopharma (2024–2026) →Melissa

Ask Jamie Chen to introduce you to Melissa

You →Jamie · together at Be Biopharma →Melissa

Ask Sam Okafor to introduce you to Melissa

You →Sam · together at ロゴマーク：AIRNA →Melissa

Sign up to find every way you can get introduced to Melissa

  • Your email: the people you already email who know Melissa
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Melissa
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

A scientist by training who joined Nextech in 2019 and holds numerous oncology biotech board seats, previously a senior associate at Third Rock Ventures.

Contact· published on Melissa's own website

Board director at Ambagon Therapeutics

Intro paths

→

In turn, Melissa can intro founders to Ambagon Therapeutics's investors below.

Ambagon Therapeutics's investors · 7

Droia VenturesLuxembourg · $540K checks · since 2021InkefAmsterdam · since 2025Mission BiocapitalSan Francisco · $500K checks · since 2025MRL Ventures FundCambridge · $25M checks · since 2025Nextech InvestZurich · $648K – $3.2M checks · since 2025RA CapitalBoston · since 2025SynconaLondon · since 2022

Co-founders at Ambagon Therapeutics

COChristian Ottmann
Christian OttmannExecutive Officer

Experience

  1. Nextech InvestPartnercurrent2021 — presentBoston, Massachusetts, United States
  2. Nextech InvestPrincipal2019 — 2021Zurich, Switzerland
  3. Tyra BiosciencesBoard Membercurrent2021 — presentCarlsbad, California, United States
  4. Alpha-9 OncologyBoard Membercurrent2022 — presentBoston, Massachusetts, United States
  5. K36 Therapeutics, Inc.Board Membercurrent2023 — presentCambridge, Massachusetts, United States
  6. Alterome Therapeutics, IncBoard Membercurrent2024 — present
  7. AIRNABoard Membercurrent2025 — present
  8. Ambagon TherapeuticsBoard Member2022 — 2026San Francisco, California, United States
  9. Be BiopharmaBoard Member2024 — 2026Cambridge, Massachusetts, United States
  10. A2 Biotherapeutics, Inc.Board Member2024 — 2026
  11. ProfoundBioBoard Observer2024
  12. Kauffman FellowsClass of 25 Fellow2020 — 2022
  13. Third Rock VenturesSenior Associate2017 — 2019
  14. Celsius TherapeuticsFounding Team Member & Business Development2018 — 2019
  15. AmgenSummer Intern2005 — 2009Thousand Oaks, CA
  16. California National Primate Research CenterLab Assistant 32006 — 2009

Skills & more

Biochemistry7Protein Purification5Cell16Molecular Biology10Science11Molecular ImagingPositron Emission TomographyGenetic EngineeringHematopoiesisWestern Blotting2Flow Cytometry1RT-PCR
+8 moreMouse ModelsGenotypingImmunologyImmunohistochemistryEnzyme AssaysReporter Gene AssaysMolecular CloningLaboratory

From Melissa's professional profile.

Investments

Per curated public sources.

Colleagues at Nextech Invest

Alessia Jaeggli
Executive Assistant at Nextech Invest
Alexis Borisy
Chairman at Nextech Invest
Alfred Scheidegger
Managing Partner at Nextech Invest
Alice T. Shaw
Science Partner at Nextech Invest
Alina Levchuk
Head of Investor Relations at Nextech Invest
Amy Nelson
Executive Assistant at Nextech Invest
Antoni Ribas
Science Partner at Nextech Invest
Benjamin Cravatt
Science Partner at Nextech Invest

Network1

Thilo Schroeder
General Partner at Nextech Partners SCSp

Investors connected to Melissa in public investor directories — a warm-intro map.

Frequently asked questions

Who is Melissa McCracken?
A scientist by training who joined Nextech in 2019 and holds numerous oncology biotech board seats, previously a senior associate at Third Rock Ventures.
Where does Melissa McCracken work?
Melissa McCracken is Partner at Nextech Invest and Board director at Ambagon Therapeutics.
What check size does Melissa McCracken write?
Melissa McCracken typically writes checks of $100K – $5M.
What companies has Melissa McCracken invested in?
Investments tracked here include Alpha-9 Oncology, Ambagon Therapeutics, BE Biopharma, K36 Therapeutics, TYRA Biosciences, ロゴマーク：AIRNA.
Where did Melissa McCracken go to school?
Melissa McCracken studied at Stanford University (Post Doc); University of California, Los Angeles (PhD, Molecular and Medical Pharmacology); University of California, Davis (BS, Biochemistry).

Same school

Shared employers